Biopharmaceuticals

BeaconEquity.com Issues Technical Trade Alerts on BioPharmaceutical Stocks: CEGE, AMLN, DNA,...

prnewswire.com     Aug 29, 2008   1 related          

BeaconEquity.com Issues Technical Trade Alerts on BioPharmaceutical Stocks: CEGE, AMLN, DNA, GENZ, AMGN, GILD DALLAS, Aug. 29 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making...                    

comments

OXiGENE Promotes Senior Executive (GlobeNewswire)

yahoo.com     Aug 29, 2008          

WALTHAM, Mass., July 15, 2008 (PRIME NEWSWIRE) -- OXiGENE, Inc. (NasdaqGM: ), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced the promotion of...                    

comments

OXiGENE Announces First Quarter 2008 Earnings Conference Call and Webcast (GlobeNewswire)

yahoo.com     Aug 29, 2008          

WALTHAM, Mass., April 28, 2008 (PRIME NEWSWIRE) -- OXiGENE, Inc. (NasdaqGM:OXGN - News ) (XSSE:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, will report...                    

comments

                   

ThromboGenics Announces Half Year Results 2008

redorbit.com     Aug 28, 2008   1 related          

LEUVEN, Belgium, August 28 /PRNewswire-FirstCall/ -- ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on innovative treatments for eye disease, vascular disease and cancer, is today issuing a...                    

comments

                   

US Pharmacies Now Supply ADHD Medication VYVANSE In 6 Dosage Strengths

medicalnewstoday.com     Aug 28, 2008   2 related          

Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, has announced that VYVANSE is now available in U.S. pharmacies nationwide in three additional dosage strengths, bringing the total...                    

comments

                   

Immunomedics Announces Fiscal 2008 Results (GlobeNewswire)

yahoo.com     Aug 28, 2008   14 related          

MORRIS PLAINS, N.J., Aug. 28, 2008 -- Immunomedics, Inc. , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported revenues of $1.0 million and...                    

comments

                   

Nabi Biopharmaceuticals Announces Second Quarter 2008 Financial Results (GlobeNewswire)

yahoo.com     Aug 28, 2008          

ROCKVILLE, Md., Aug. 7, 2008 -- Nabi Biopharmaceuticals today announced its second quarter financial results for the three month period ended June 28, 2008. The Company reported a net loss from continuing operations of...                    

comments

                   

Orexigen(R) Therapeutics to Present at Upcoming Investor Conferences

finanznachrichten.de     Aug 28, 2008          

SAN DIEGO, Aug. 28 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. , a biopharmaceutical company focused on the treatment of central nervous system disorders, including obesity, today announced that the Company...                    

comments

pharmiweb.co.uk: SAN DIEGO - ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at The Thomas Weisel Partners 200 pharmiweb.co.uk

ACADIA Pharmaceuticals to Present at The Thomas Weisel Partners Healthcare Conference on...

pharmiweb.co.uk     Aug 28, 2008          

SAN DIEGO - (Business Wire) ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous...                    

comments

Synta Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference

pharmiweb.co.uk     Aug 28, 2008          

LEXINGTON, Mass. - (Business Wire) Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions,...                    

comments